Vaccines and reported side effects
In a no- holds- barred interview, Consultant Immunologist Dr. Rajiva de Silva holds up all the concerns against vaccination to the light and gives scientific evidence collated across the world and ground- level investigations on reported severe side effects.
Alleged cases of anaphylaxis after the Pfizer booster
He says that quite a lot of patients with so-called anaphylaxis after vaccination have been investigated individually in Sri Lanka – “we have found that these people have had only fainting attacks and not anaphylaxis”.
“This is called vasovagal syncope which comes about when you faint as your body overreacts to certain situations, such as the sight of blood or extreme emotional distress. It causes your heart rate and blood pressure to drop suddenly,” he says, explaining that they have done over 35 tests on serum levels on such people to confirm/ discount anaphylaxis. All the indicators were negative for anaphylaxis.
Eruption of hives after vaccination
Dr. de Silva touches on instances where some people have got hives or urticaria – red, itchy welts, varying in size and appearance that result from a skin reaction – about fourhours after the vaccine dose. There could also be delayed hives, a day or two after the vaccine. This may happen but it is not serious.
High fever, body aches and pains and malaise (lethargy)
“This is basically part of the immune reaction. So when someone gets a very strong immune reaction, it indicates that the immune system is responding well and there is no cause for concern,” Dr. de Silva says.
Blood clots after the 1st dose
Recalling that there was a rare issue of blood clots with the 1st dose of AstraZeneca very early on, he stressed that it was not seen with the 2nd dose. The treatment too was not ideal then. Now scientists have found out the exact way it happened, the system has been formalized and deaths prevented. It is no longer a concern because now AstraZeneca is not being administered in the country.
Myocarditis and pericarditis in children after Pfizer
Dr. de Silva says that this occurred “very rarely” in males below 30 years of age, especially in the 16-20 age group, after the 2nd dose. In an overwhelming majority of these rare instances, it was mild, but no one knows exactly why this happened.
Some people believe that it happened in Canada, the United States of America ( USA) and the United Kingdom because when administering the vaccine, the syringe plunger is not withdrawn immediately. As such, the vaccine may enter blood vessels directly. However, in Sri Lanka and a few other countries, the plunger is withdrawn, he said, adding that Paediatricians have not recorded any cases of myocarditis among boys who have been given the 2nd dose.
Meanwhile, they have found that when the interval between the first two doses is delayed from 4 weeks to 8-12 weeks, the incidence of myocarditis goes down. In Sri Lanka, the second dose for the over 16 age group is given three months after. Even if a boy suffers mild myocarditis, the prognosis is good as there is good management in Sri Lanka. However, everyone is advised not to engage in strenuous physical activity for 2 weeks after vaccination.
Allegations of myocardial infarction (heart attacks), pulmonary embolisms (blood clots going to the lungs) & strokes
Quoting an article on myocardial infarction, stroke and pulmonary embolism after the Pfizer vaccine in people aged 75 years or older, published in the Journal of the American Medical Association (JAMA) on January 4, this year (2022), Dr. de Silva says the results were reported thus:
In this nationwide study involving persons aged 75 years or older in France, no increase in the incidence of acute myocardial infarction, stroke and pulmonary embolism was detected 14 days following each vaccine dose.Israel and US studies reported that persons receiving the vaccine were not at increased risk of myocardial infarction, pulmonary embolism or cerebrovascular events ( strokes) in the 42 days and 21 days following vaccination.
According to Dr. de Silva, another study published in the New England Journal of Medicine (NEJM) on September 16, 2021 ( last year) using data from the largest healthcare organization in Israel states:
In this nationwide mass vaccination setting, the Pfizer vaccine was not associated with an elevated risk of most of the adverse events examined. The vaccinated and control groups had each included 884,828 people respectively.